Basel, Switzerland

Yasuchika Yamaguchi

This inventor holds 6 USPTO granted patents. Top assignees: Ciba-Geigy Corporation, Novartis Corporation. Active years: 1994-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yasuchika Yamaguchi. Retrieved from https://idiyas.com/inventor/yasuchika-yamaguchi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.3

ph-index = 5

Forward Citations = 101(Granted Patents)


Company Filing History:


Years Active: 1994-1998

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Inventor Yasuchika Yamaguchi

Introduction: Yasuchika Yamaguchi is a renowned inventor based in Basel, Switzerland. He is known for his groundbreaking contributions to the field of pharmaceuticals and biotechnology.

Latest Patents: Yamaguchi holds several patents in the areas of drug delivery systems, personalized medicine, and novel therapeutic compounds. His innovative approach to drug development has revolutionized the industry.

Career Highlights: With a background in biochemistry and pharmacology, Yamaguchi has worked for leading pharmaceutical companies in Switzerland, where he has spearheaded research projects that have led to the development of life-saving medications.

Collaborations: Throughout his career, Yamaguchi has collaborated with top researchers, scientists, and medical professionals from around the world. His collaborative efforts have resulted in the successful commercialization of several cutting-edge medical technologies.

Conclusion: Yasuchika Yamaguchi's dedication to innovation and his passion for improving healthcare have solidified his reputation as a pioneering inventor in the field of pharmaceuticals. His work continues to have a profound impact on the lives of people globally.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…